Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuvan in GTPCH deficiency
NCT01425528Phase 2Completed
- Sponsor
- University of Utah
- Start
- Aug 2011
- Primary completion
- Aug 2013
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in GTP cyclohydrolase 1 deficiency, sponsored by University of Utah. Started Aug 2011; status: completed.
02
Drugs
sapropterin
03
Conditions
GTP cyclohydrolase 1 deficiency
Beyond the preview
Go deeper on NCT01425528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425528.